RxDoctor Payments Data

Itunu Owoyemi, MD

Nephrology · Kansas City, KSNPI 1336580455

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $412 and has fallen 74.8% since, to $104 in 2025. That places this record below the midpoint for nephrology clinicians in KS, where the typical reported total is $931.

$931in general payments, 2019–2025

Across 13 payments — averaging $71.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$144
  • Bayer$142
  • Novo Nordisk$135
  • Vifor Pharma, Inc.$115
  • Veloxis Pharmaceuticals, Inc.$104
  • Sanofi$100
  • plus $192 from 4 others

What the payments were for

  • Food & beverage$931100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$931 in reported general payments places this provider in the 50th percentile of 55 nephrology providers in Kansas.

See all nephrology providers in Kansas

Medicare billing

Part B allowed, 2024
$39,268
Medicare patients
181
Services billed
355

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VeltassaPatiromer Calcium Sorbitex11$12,967
Cinacalcet Hcl39$3,216
Valganciclovir Hcl17$2,465
Nifedipine ErNifedipine62$1,251
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim109$884
Losartan Potassium128$821
Metoprolol Succinate58$579
Prednisone105$469
Atorvastatin Calcium87$382
Amlodipine Besylate75$343
Famotidine49$335
Metformin Hcl ErMetformin Hcl39$331
Carvedilol39$191
Chlorthalidone15$187
Lisinopril29$168

Paid to pharmacies, not to this prescriber.

Other nephrology in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →